3DPrint.com October 11, 2024
Sarah Saunders

Last year, Baltimore-based medical device company Kallisio received FDA 510(k) clearance for its 3D printed patient-specific Stentra device. Oral stents like this are critically important in protecting a patient’s healthy tissue during radiation treatments for head and neck cancers (HNC). Now, the company has announced a strategic partnership with RICOH 3D for Healthcare to make and distribute Stentra to improve radiation oncology care.

“Partnering with RICOH 3D for Healthcare is a natural fit for our mission to transform cancer care. Ricoh’s expertise in advanced manufacturing and their robust distribution network, including point-of-care production capabilities and clinical applications team, make them an ideal partner,” said Kallisio CEO Rajan Patel. “Together, we can ensure that Stentra™ reaches radiation oncology teams efficiently,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: 3D Printing, Technology
Related Articles:
How 3D Printing Impacts Radiology
Ricoh’s 3D Printing Improves Surgical Accuracy and Safety One Layer at a Time
3D-printed hydrogel enables continuous drug delivery via contact lens
Improved 3D printed blood vessels thanks to bioink with DNA
DNA-based bioink technology enables precise 3D-printing of blood vessels

Share This Article